Quantum BioPharma is trading at $2.81, up 5.53% after hours, with no clear company-specific catalyst identified.

  • This compares with the October 14 regular-session close of $2.66.
  • Search results surfaced an October 6 Thermo Fisher trial agreement and a summit announcement first issued September 15; neither was new on October 14.
  • Major indexes fell on October 14, but available evidence does not establish a reason for the after-hours move.